tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Citius Pharmaceuticals Regains Nasdaq Compliance
PremiumCompany AnnouncementsCitius Pharmaceuticals Regains Nasdaq Compliance
3M ago
Citius Oncology expects commercial launch of Lymphir in second half of 2025
Premium
The Fly
Citius Oncology expects commercial launch of Lymphir in second half of 2025
4M ago
Citius Pharmaceuticals Closes $6M Securities Offering
Premium
Company Announcements
Citius Pharmaceuticals Closes $6M Securities Offering
4M ago
Citius Pharmaceuticals Issues $1M Promissory Note to Pagoda
PremiumCompany AnnouncementsCitius Pharmaceuticals Issues $1M Promissory Note to Pagoda
4M ago
Citius Pharmaceuticals downgraded to Hold from Buy at Maxim
Premium
The Fly
Citius Pharmaceuticals downgraded to Hold from Buy at Maxim
5M ago
Citius Pharmaceuticals Reports Q1 2025 Earnings and Strategic Developments
Premium
Company Announcements
Citius Pharmaceuticals Reports Q1 2025 Earnings and Strategic Developments
5M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
7M ago
Citius Pharmaceuticals announces $2M registered direct offering of common stock
Premium
The Fly
Citius Pharmaceuticals announces $2M registered direct offering of common stock
7M ago
Citius Pharma Advances LYMPHIR Launch Amid Financial Updates
Premium
Company Announcements
Citius Pharma Advances LYMPHIR Launch Amid Financial Updates
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100